In 2024, we need US$1.5 billion to provide live-saving health care to millions of people in emergencies. An alarming combination of conflict, climate-related threats and increasing economic hardship mean an estimated 166 million people require health assistance.
Le Plan de réponse humanitaire (PRH) 2020 a été révisé et publié en mai 2020 afin d’intégrer l’impact de l’épidémie de COVID-19 sur les besoins humanitaires existants et sur les activités des partenaires humanitaires.
Nosocomial infections, or hospital-acquired infec-tions (HAI), are among the most significant causesof morbidity and mortality in healthcare settingsthroughout the world.Prevention of HAIs iscentral to providing high quality and safe health-care, even in settings with limited resources.Transmi...ssion of infectious agents between patientsby health workers and irrational use of antibioticsare two important preventable factors involved inmany HAIs.
more
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
La promotion de la santé est un moyen efficace pour accroître la participation individuelle et collective à l’action sanitaire, susciter la demande des produits de santé et favoriser l’utilisation des services de soins. L’approche a été recommandée en 1986 suite à l’adoption de la ch...arte d’Ottawa par les États membres de l’Organisation mondiale de la santé (OMS). Depuis cette
date, plusieurs conférences internationales ont porté sur l’élucidation de différents aspects de la charte. De nouvelles données ont éveillé les consciences sur les inégalités de santé et encouragé les États à agir dans le sens de l’équité en matière de santé.
more
Principles and Target Product Criteria. Roadmap January 12, 2015
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...).
This document is a practical tool designed to help health workers improve clinical diagnosis and provide timely care for patients infected
with the dengue, chikungunya, or Zika virus. It is intended mainly for
health workers in primary care facilities where laboratory diagnosis of
arboviruses is not always available. However, this guide may also be
very useful in hospitals that provide second- and third-level care, as it
describes the clinical manifestations of each of the three most important
arboviral diseases currently found in the Region, the elements for
differential diagnosis, and their clinical behavior.
more
10 years after the UN general assembly special session on drugs
Reprinted from Australian Family Physician Vol. 39, No. 10, october 2010
International Journal of Infectious Diseases 80 (2019) 10–15
journal homepage: www.elsevier.com/locate/ijid